These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21299463)

  • 1. Molecular evidence of a genotypically novel large T-cell lymphoma after anti-CD4 therapy for refractory mycosis fungoides.
    Papalas JA; Sebastian S; Wang E
    Leuk Lymphoma; 2011 May; 52(5):905-7. PubMed ID: 21299463
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycosis fungoides arthropathy.
    Berger RG; Knox SJ; Levy R; Sklar JL; Cohen P; Reichert T
    Ann Intern Med; 1991 Apr; 114(7):571-2. PubMed ID: 1825772
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraocular T-cell lymphoma due to mycosis fungoides and response to intravitreal methotrexate.
    Reddy R; Kim SJ
    Ocul Immunol Inflamm; 2011 Aug; 19(4):234-6. PubMed ID: 21770799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of mycosis fungoides with large cell transformation associated with infliximab treatment.
    Suga H; Sugaya M; Toyama T; Sumida H; Fujita H; Kogure A; Igarashi A; Sato S
    Acta Derm Venereol; 2014 Mar; 94(2):233-4. PubMed ID: 23975254
    [No Abstract]   [Full Text] [Related]  

  • 5. Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.
    Lesokhin AM; Ansell SM; Armand P; Scott EC; Halwani A; Gutierrez M; Millenson MM; Cohen AD; Schuster SJ; Lebovic D; Dhodapkar M; Avigan D; Chapuy B; Ligon AH; Freeman GJ; Rodig SJ; Cattry D; Zhu L; Grosso JF; Bradley Garelik MB; Shipp MA; Borrello I; Timmerman J
    J Clin Oncol; 2016 Aug; 34(23):2698-704. PubMed ID: 27269947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patients.
    Bouwhuis SA; Davis MD; el-Azhary RA; McEvoy MT; Gibson LE; Knudsen JM; Kist JM; Pittelkow MR
    J Am Acad Dermatol; 2005 Jun; 52(6):991-6. PubMed ID: 15928617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations on the effect of chimeric anti-CD4 monoclonal antibody in patients with mycosis fungoides.
    Knox SJ; Levy R; Hodgkinson S; Bell R; Brown S; Wood GS; Hoppe R; Abel EA; Steinman L; Berger RG
    Blood; 1991 Jan; 77(1):20-30. PubMed ID: 1984796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphocytic colitis, followed by collagenous colitis, associated with mycosis fungoides-type T-cell lymphoma].
    Ouyahya F; Michenet P; Gargot D; Breteau N; Buzacoux J; Legoux JL
    Gastroenterol Clin Biol; 1993; 17(12):976-7. PubMed ID: 8125237
    [No Abstract]   [Full Text] [Related]  

  • 9. Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center.
    Querfeld C; Mehta N; Rosen ST; Guitart J; Rademaker A; Gerami P; Kuzel TM
    Leuk Lymphoma; 2009 Dec; 50(12):1969-76. PubMed ID: 19860617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large cell transformation mimicking regional lymphomatoid papulosis in a patient with mycosis fungoides.
    Nakahigashi K; Ishida Y; Matsumura Y; Kore-Eda S; Ohmori K; Fujimoto M; Yamashita K; Kotani H; Sakurai T; Miyachi Y
    J Dermatol; 2008 May; 35(5):283-8. PubMed ID: 18477228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients.
    Marschalkó M; Erős N; Kontár O; Hidvégi B; Telek J; Hársing J; Jókai H; Bottlik G; Rajnai H; Szepesi Á; Matolcsy A; Kárpáti S; Csomor J
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):964-72. PubMed ID: 25406034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cutaneous T-cell lymphoma with chimeric anti-CD4 monoclonal antibody.
    Knox S; Hoppe RT; Maloney D; Gibbs I; Fowler S; Marquez C; Cornbleet PJ; Levy R
    Blood; 1996 Feb; 87(3):893-9. PubMed ID: 8562959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac involvement with mycosis fungoides: could this explain alemtuzumab toxicity?
    Sleigh KA; Smith ME; Rule SA
    Leuk Lymphoma; 2008 Oct; 49(10):2022-4. PubMed ID: 18452071
    [No Abstract]   [Full Text] [Related]  

  • 14. Concomitant occurrence of kimura disease and mycosis fungoides in a Lebanese woman: significance and response to rituximab.
    Ghosn S; Bahhady R; Mahfouz R; Abbas O; Kibbi AG; Saad R; Taher A
    Am J Dermatopathol; 2009 Dec; 31(8):814-8. PubMed ID: 19786854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphomatoid papulosis associated with mycosis fungoides: clinicopathological and molecular studies of 12 cases.
    Gallardo F; Costa C; Bellosillo B; Solé F; Estrach T; Servitje O; García-Muret MP; Barranco C; Serrano S; Pujol RM
    Acta Derm Venereol; 2004; 84(6):463-8. PubMed ID: 15844638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycosis fungoides occurring at the site of previous herpes zoster eruption.
    Huang S; Kim EJ; Lewis DJ; Chan WH; Miranda RN; Duvic M
    Australas J Dermatol; 2018 Aug; 59(3):217-219. PubMed ID: 29280139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycosis fungoides: an important differential diagnosis for acquired palmoplantar keratoderma.
    Kim J; Foster R; Lam M; Kumarasinghe SP
    Australas J Dermatol; 2015 Feb; 56(1):49-51. PubMed ID: 24575903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha is effective for CD4(+), CCR4(-) mycosis fungoides.
    Fujimura T; Okuyama R; Watabe A; Hashimoto A; Tagami H; Aiba S
    Int J Dermatol; 2007 Apr; 46(4):435-8. PubMed ID: 17442093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deafness from eighth cranial nerve involvement in a patient with large-cell transformation of mycosis fungoides.
    Chua SL; Seymour JF; Prince HM
    Eur J Haematol; 2000 May; 64(5):340-3. PubMed ID: 10863980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
    Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
    Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.